etomoxir has been researched along with 5-(tetradecyloxy)-2-furancarboxylic acid in 3 studies
Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (5-(tetradecyloxy)-2-furancarboxylic acid) | Trials (5-(tetradecyloxy)-2-furancarboxylic acid) | Recent Studies (post-2010) (5-(tetradecyloxy)-2-furancarboxylic acid) |
---|---|---|---|---|---|
260 | 8 | 93 | 51 | 0 | 16 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuhajda, FP; Pinn, ML; Thupari, JN | 1 |
Kuhajda, FP; McFadden, JM; Medghalchi, SM; Pinn, ML; Ronnett, GV; Simpson, PJ; Townsend, CA; Vadlamudi, A; Zhou, W | 1 |
Atencio, AE; Gallucci, S; Qiu, CC | 1 |
3 other study(ies) available for etomoxir and 5-(tetradecyloxy)-2-furancarboxylic acid
Article | Year |
---|---|
Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
Topics: Acetyl-CoA Carboxylase; Apoptosis; Breast Neoplasms; Carnitine O-Palmitoyltransferase; Cell Survival; Cerulenin; Enzyme Inhibitors; Epoxy Compounds; Fatty Acid Synthases; Fatty Acids; Female; Furans; Humans; Hypolipidemic Agents; Kinetics; Malonyl Coenzyme A; Models, Biological; Oxidation-Reduction; Tumor Cells, Cultured | 2001 |
Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Topics: 4-Butyrolactone; Apoptosis; Breast Neoplasms; Carnitine O-Palmitoyltransferase; Cell Division; Cell Line, Tumor; Drug Interactions; Epoxy Compounds; Fatty Acid Synthases; Furans; Humans; Membrane Lipids; Phospholipids; S Phase | 2003 |
Inhibition of fatty acid metabolism by etomoxir or TOFA suppresses murine dendritic cell activation without affecting viability.
Topics: Animals; Cell Survival; Cytokines; Dendritic Cells; Epoxy Compounds; Fatty Acids; Furans; Mice; Toll-Like Receptor 9 | 2019 |